Zosano Pharma Corporation

NASDAQ: ZSANHealthcare / Biotechnology / USA
3.07+0.0100+0.33%Vol 169 6391Y Perf -26.08%
Jun 20th, 2019 16:00
BID3.03 ASK3.10
Open3.13 Previous Close3.06
Pre-Market3.10 After-Trading3.08
 0.04 1.31%  0.01 0.33%
Target Price
13.00 
Analyst Rating
Strong Buy 1.00
Potencial %
323.45 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)54 
Earnings Rating
Neutral
Price Range Ratio 52wk %
25.42 
Earnings Date
8th Aug 2019

Today's Price Range

3.063.19

52wk Range

1.856.65

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
9.29%
3 Months
-35.98%
6 Months
11.27%
1 Year
-26.08%
3 Years
-89.15%
5 Years
-

Name / TickerPriceChg.Chg.%
ZSAN3.070.01000.33
AAPL199.461.59000.80
GOOG1 111.429.09000.82
MSFT136.951.26000.93
XOM76.611.29001.71
WFC45.860.21000.46
JNJ142.211.76001.25
FB189.532.05001.09
GE10.630.29002.80
JPM110.190.28000.25
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.79-
Q04 2018--0.85-
Q02 2018--0.75-
Q01 2018--4.16-
Q04 2017-4.80-3.8020.83
Q03 2017-3.00-4.00-33.33
Q02 2017-3.00-3.40-13.33
Q01 2017-6.00-6.80-13.33
Earnings Per EndEstimateRevision %Trend
3/2018 QR-5.400.00-
6/2018 QR-4.200.00-
12/2019 FY-2.58--
12/2020 FY-2.46--
Next Report Date8th Aug 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume169 639
Shares Outstanding (in ths.)17 723
Trades Count454
Dollar Volume504 759
Avg. Volume1 399 536
Avg. Weekly Volume242 761
Avg. Monthly Volume225 045
Avg. Quarterly Volume557 247
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Zosano Pharma Corporation

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications. The company operates in one business segment which is developing human pharmaceutical products. All the business activity of the firm is functioned through the market of the United States. Its product includes Qtrypta (M207) which is a formulation of zolmitriptan delivered utilizing an Adhesive Dermally-Applied Microarray technology.

CEO: John P. Walker

Teplephone: +1 510 745-1200

Address: 34790 Ardentech Court, Fremont 94555, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

48%52%

Bearish Bullish

65%35%

News